Metraipolis › archive › dc_ab8ca17626d0
Effect of SGLT-2 inhibitors on liver fibrosis progression in patients with MASLD: an updated meta-analysis based on RCTs — Europe PMC PMID:41641245
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41641245
- DOI
- 10.3389/fmed.2025.1667823
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T16:41:05.712Z
- SHA-256 of the archived text
0a5c58a35ebe246cf5733faa6cd0a76dcae0fd81db0884389f7c46740101929e- Stable URL of this page
https://metraipolis.com/documento/dc_ab8ca17626d0
How to cite
Effect of SGLT-2 inhibitors on liver fibrosis progression in patients with MASLD: an updated meta-analysis based on RCTs — Europe PMC PMID:41641245 — Europe PMC (en), https://europepmc.org/article/MED/41641245 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ab8ca17626d0 (Metraipolis archive dc_ab8ca17626d0, sha256 0a5c58a35ebe246cf5733faa6cd0a76dcae0fd81db0884389f7c46740101929e)
BibTeX
@misc{dcab8ca17626d0,
title = {Effect of SGLT-2 inhibitors on liver fibrosis progression in patients with MASLD: an updated meta-analysis based on RCTs — Europe PMC PMID:41641245},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41641245},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ab8ca17626d0; sha256 0a5c58a35ebe246cf5733faa6cd0a76dcae0fd81db0884389f7c46740101929e},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41641245. Agents can read the archived copy with the MCP tool read_document.